Unusually High Titres of Antibodies to Rubella Virus in a Patient with Chronic Hepatitis

References

• Becker, M. D., Scheuer, P. J., Baptista, A. & Sherlock, S.: Prognosis of chronic persistent hepatitis. Lancet 1: 53, 1970.
   PubMed Web of Science ®Google Scholar
• Björneboe, M., Jensen, K. B., Scheibel, I., Thomsen, A. C. & Benzon, M.: Tetanus antitoxin production and gamma globulin levels in patients with cirrhosis of the liver. Acta Med Scand 188: 541, 1970.
   PubMedGoogle Scholar
• Buckley, B. H., Heizer, W. D., Goldfinger, S. E., Isselbacher, K. J. & Schulman, N. R.: Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. Lancet 2: 1323, 1970.
   Google Scholar
• Cherrick, G. R., Pothier, L., Dufour, J. J. & Sherlock, S.: Immunologic response to tetanus toxoid inoculation in patients with hepatic cirrhosis. N Engl J Med 261: 340, 1959.
   PubMed Web of Science ®Google Scholar
• Cooper, L. Z., Matters, B., Rosenblum, J. K. & Krugman, S.: Experience with a modified rubella hemagglutination inhibition antibody test. JAMA 207: 89, 1969.
   PubMed Web of Science ®Google Scholar
• Doniach, D., Roitt, I. M., Walker, J. G. & Sherlock, S.: Tissue antibodies in primary biliary cirrhosis, actice chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol 1: 237, 1966.
   PubMedGoogle Scholar
• Doniach, D., Walker, J. G., Roitt, I. M. & Berg, P. A.: “Autoallergic” hepatitis. N Engl J Med 282: 86, 1970.
   PubMedGoogle Scholar
• Feizi, T.: Immunoglobulins in chronic liver disease. Gut 9: 193, 1968.
   PubMed Web of Science ®Google Scholar
• Fox, R. A., Niazi, S. P. & Sherlock, S.: Hepatitis-associated antigen in chronic liver disease. Lancet 2: 609, 1969.
   PubMedGoogle Scholar
• Gelzayd, E. A. & Kirsner, J. B.: Immunologic aspects of chronic active hepatitis in young people: A critical review of the recent literature. Am J Med Sci 253: 98, 1967.
   Google Scholar
• Gentilini, P., Surrenti, C., Salvadori, G., Casini, M. C. & Chiarantini, C.: Chronic aggressive hepatitis in a woman with hypogammaglobulinaemia. Abstract no. 77 of the 6th Meeting of the European Association for the Study of the Liver. London 1971
   Google Scholar
• Gerson, K. L. & Haslam, R. H. A.: Subtle immunologic abnormalities in four boys with subacute sclerosing panencephalitis. N Engl J Med 285: 78, 1971.
   Google Scholar
• Gitnick, G. L., Gleich, G. J., Schoenfield, L. J., Baggenstoss, A. H., Sutnick, A. J., Blumberg, B. S., London, W. T. & Summershill, W. H. J.: Australia antigen in chronic active liver disease with cirrhosis. Lancet 2, 285, 1969.
   PubMedGoogle Scholar
• Good, R. A. & Page, A. R.: Fatal complications of virus hepatitis in two patients with agammaglobulinaemia. Am J Med 29: 804, 1960.
   PubMed Web of Science ®Google Scholar
• De Groote, J., Desmet, V. J., Gedigk, P., Korb, G., Popper, H., Poulsen, H., Scheuer, P. J., Schmid, M., Thaler, H., Uehlinger, E. & Wepler, W.: A classification of chronic hepatitis. Lancet 2: 626, 1968.
   PubMed Web of Science ®Google Scholar
• Haukenes, G. & Aasen, J.: Rubella haemagglutination inhibitors: Their separation from antibodies. Acta Pathol Microbiol Scand [B] 79: 679, 1971.
   Google Scholar
• Havens, W. P., Schaffer, J. M. & Hopke, C. J.: The production of antibodies by patients with chronic hepatic disease. J Immunol 67: 347, 1951.
   Google Scholar
• Havens, W. P., Myerson, R. M. & Klackho, J.: Production of tetanus antitoxin by patients with hepatic cirrhosis. N Engl J Med 257: 637, 1957.
   Google Scholar
• Krook, H.: Liver cirrhosis in patients with a lupus erythematosus-like syndrome. Acta Med Scand 169: 713, 1961.
   Google Scholar
• MacLachlan, M. J., Rodnan, G. P., Cooper, W. M. & Fennell, R. H.: Chronic active (“lupoid”) hepatitis. Ann Intern Med 62: 425, 1965.
   PubMed Web of Science ®Google Scholar
• Mistilis, S. P. & Blackburn, C. R. P.: Active chronic hepatitis. Am J Med 48: 484, 1970.
   PubMed Web of Science ®Google Scholar
• Montgomery, J. R., South, M. A., Rawls, W. E., Melnick, J. L., Olson, G. B., Dent, P. D. & Good, R. A.: Viral inhibition of lymphocytic response to phytohemagglutinin. Science 157: 1068, 1967.
   PubMed Web of Science ®Google Scholar
• Olson, G. B., South, M. A. & Good, R. A.: Phytohemagglutinin unresponsiveness of lymphocytes from babies with congenital rubella. Nature 214: 695, 1967.
   PubMed Web of Science ®Google Scholar
• Protell, R. L., Soloway, R. D., Martin, W. J., Schoenfield, L. J. & Summershill, W. H. J.: Anti-salmonella agglutinins in chronic active liver disease. Lancet 2: 330, 1971.
   PubMed Web of Science ®Google Scholar
• Read, A. E., Sherlock, S. & Harrison, S. U.: Active “juvenile” cirrhosis considered as a part of a systemic disease and effect of corticosteroid therapy. Gut 4: 378, 1963.
   PubMed Web of Science ®Google Scholar
• Sherlock, S.: The immunology of liver disease. Am J Med 49: 693, 1970.
   PubMed Web of Science ®Google Scholar
• Sirtori, C.: Viruses and immunosuppressant drugs. Lancet 2: 768, 1970.
   Google Scholar
• Söborg, M. & Tygstrup, N.: Increased cellular immunological response in patients with chronic liver disease. Scand J Gastroenterol, Suppl. 7: 43, 1970.
   Google Scholar
• Stern, H.: Isolation of rubella virus in a case of giant-cell hepatitis. Lancet 1: 293, 1966.
   Google Scholar
• Stewart, G. L., Parkman, P. D., Hopps, H. E., Douglas, R. D., Hamilton, J. P. & Meyer, H. M.: Rubella-virus hemagglutination-inhibition test. N Engl J Med 276: 554, 1967.
   PubMed Web of Science ®Google Scholar
• Talal, N.: Immunologic and viral factors in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 13: 887, 1970.
   PubMedGoogle Scholar
• Watson, J. R. H.: Hepatosplenomegaly as a complication of maternal rubella. Med J Aust 1: 516, 1952.
   Google Scholar
• Wright, R., McCollum, R. W. & Klatskin, C.: Australia antigen in acute and chronic liver disease. Lancet 2: 117, 1969.
   PubMed Web of Science ®Google Scholar